Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-J Body

Showing results (151-160 of 213) with videos related to

Pageof 22
Sort By:
Presse Medicale (Paris, France : 1983)|June 10, 1989
[Adoptive immunotherapy with interleukin 2. Initial results of a pilot study in 6 cancer patients]J P Sculier, D Bron, A Delforge, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 1, 1989
Septicemias in cancer patients during parenteral nutrition: contributing factors and detection by weekly blood culturesJ J Body, V Richard, J C Pector, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 5, 2005
Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapyE De Cock, J Hutton, P Canney, et al.
Revue Medicale De Liege|August 15, 2000
[Involutional osteoporosis in women: therapeutic strategy. Recommendations of the Belgian Bone Club]J M Kaufman, J J Body, S Boonen, et al.
British Journal of Cancer|March 18, 2004
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studiesJ J Body, I J Diel, M Lichinitzer, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 1, 2004
Hypovitaminosis D in a normal, apparently healthy urban European populationG D MacFarlane, J L Sackrison, J J Body, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 25, 2012
Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paperR Rizzoli, J J Body, A DeCensi, et al.
European Journal of Cancer|December 1, 1980
Carminomycin (NSC-180024): a phase I studyR Abele, M Rozencweig, J J Body, et al.
Journal of Endocrinological Investigation|February 1, 1990
Contribution of thyroid ultrasound and serum calcitonin to the diagnosis of congenital hypothyroidismJ P Chanoine, V Toppet, J J Body, et al.
Calcified Tissue International|October 18, 2002
Investigation of bone disease using isomerized and racemized fragments of type I collagenP A C Cloos, C Fledelius, S Christgau, et al.
Pageof 22

Showing results (151-160 of 213) with videos related to

Sort By:
Pageof 22
Presse Medicale (Paris, France : 1983)|June 10, 1989
[Adoptive immunotherapy with interleukin 2. Initial results of a pilot study in 6 cancer patients]J P Sculier, D Bron, A Delforge, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 1, 1989
Septicemias in cancer patients during parenteral nutrition: contributing factors and detection by weekly blood culturesJ J Body, V Richard, J C Pector, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 5, 2005
Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapyE De Cock, J Hutton, P Canney, et al.
Revue Medicale De Liege|August 15, 2000
[Involutional osteoporosis in women: therapeutic strategy. Recommendations of the Belgian Bone Club]J M Kaufman, J J Body, S Boonen, et al.
British Journal of Cancer|March 18, 2004
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studiesJ J Body, I J Diel, M Lichinitzer, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 1, 2004
Hypovitaminosis D in a normal, apparently healthy urban European populationG D MacFarlane, J L Sackrison, J J Body, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 25, 2012
Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paperR Rizzoli, J J Body, A DeCensi, et al.
European Journal of Cancer|December 1, 1980
Carminomycin (NSC-180024): a phase I studyR Abele, M Rozencweig, J J Body, et al.
Journal of Endocrinological Investigation|February 1, 1990
Contribution of thyroid ultrasound and serum calcitonin to the diagnosis of congenital hypothyroidismJ P Chanoine, V Toppet, J J Body, et al.
Calcified Tissue International|October 18, 2002
Investigation of bone disease using isomerized and racemized fragments of type I collagenP A C Cloos, C Fledelius, S Christgau, et al.
Pageof 22